DNMT1 and leukemia: On the basis of the studies above, Hassan et al. further investigated the cytotoxic effects and epigenetic changes associated with the combination of DiMC and the DNMT inhibitor decitabine (DAC) in primary leukemia samples and cell lines CEM and Jurkat (Hassan et al., 2016).